Phase I immunotherapy with a modified vaccinia virus (MVA)...

Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer

Professor Christoph Rochlitz, Robert Figlin, Patrick Squiban, Marc Salzberg, Miklos Pless, Richard Herrmann, Eric Tartour, Yongxiang Zhao, Nadine Bizouarne, Martine Baudin, Bruce Acres
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
5
Year:
2003
Language:
english
Pages:
10
DOI:
10.1002/jgm.397
File:
PDF, 145 KB
english, 2003
Conversion to is in progress
Conversion to is failed